Compare Covidh Technolog with Similar Stocks
Dashboard
With a Negative Book Value, the company has a Weak Long Term Fundamental Strength
- Poor long term growth as Net Sales has grown by an annual rate of % and Operating profit at 0% over the last 5 years
- The company has a negative book value of Rs 0.11 crore
Flat results in Dec 25
Risky - Negative EBITDA
Stock DNA
Miscellaneous
INR 65 Cr (Micro Cap)
543.00
35
0.00%
-1.61
-12.00%
-65.16
Total Returns (Price + Dividend) 
Latest dividend: 0.5 per share ex-dividend date: Sep-20-2013
Risk Adjusted Returns v/s 
Returns Beta
News

Covidh Technologies Ltd is Rated Sell
Covidh Technologies Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 03 Jul 2025. However, the analysis and financial metrics discussed below reflect the stock's current position as of 05 May 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook.
Read full news article
Broad-Based Technical Strength Lifts Covidh Technologies Ltd to 52-Week High of Rs 77.49
After a sustained rally spanning 21 consecutive trading sessions, Covidh Technologies Ltd surged to a new 52-week high of Rs 77.49 on 28 Apr 2026, marking a remarkable 49.05% gain over this period. This milestone reflects a powerful momentum shift underpinned by a confluence of bullish technical indicators across multiple timeframes.
Read full news article
Broad-Based Technical Strength Lifts Covidh Technologies Ltd to 52-Week High of Rs 76.99
After a sustained rally spanning 21 consecutive trading sessions, Covidh Technologies Ltd surged to a new 52-week high of Rs 76.99 on 27 Apr 2026, marking a remarkable 51.02% gain over this period and signalling robust momentum across multiple technical indicators.
Read full news article Announcements 
Announcement under Regulation 30 (LODR)-Newspaper Publication
22-Apr-2026 | Source : BSESubmission of Newspaper Advertisement of Postal Ballot Notice pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015.
Announcement under Regulation 30 (LODR)-Acquisition
21-Apr-2026 | Source : BSEThe Board of Directors considered and approved the acquisition of equity shares representing up to 100% of the paid-up equity share capital of iSERA Biological Limited (an unlisted public company CIN: U85300PN2016PLC165483) comprising up to 16182800 (One Crore Sixty-One Lakh Eighty-Two Thousand Eight Hundred) equity shares of face value Rs. 10/- (Rupees Ten Only) each from the existing shareholders of iSERA Biological Limited for a total consideration of Rs. 780010960/- (Rupees Seventy-Eight Crore Ten Thousand Nine Hundred and Sixty Only) to be discharged entirely by way of issuance and allotment of up to 16182800 (One Crore Sixty-One Lakh Eighty-Two Thousand Eight Hundred) fully paid-up equity shares of iSERA Lifesciences Limited (Formerly known as Covidh Technologies Limited)
Shareholder Meeting / Postal Ballot-Notice of Postal Ballot
21-Apr-2026 | Source : BSEPursuant to the resolution passed by the Board of Directors of the Company at its meeting held on Tuesday April 21 2026 the Company encloses herewith the Postal Ballot Notice dated April 21 2026 seeking the approval of the Members of the Company by way of Postal Ballot / Remote E-Voting on the following matters
Corporate Actions 
No Upcoming Board Meetings
Covidh Technologies Ltd has declared 5% dividend, ex-date: 20 Sep 13
No Splits history available
No Bonus history available
Covidh Technologies Ltd has announced 25:1 rights issue, ex-date: 24 Oct 25
Quality key factors 
Valuation key factors
Technicals key factors
Shareholding Snapshot : Mar 2026
Shareholding Compare (%holding) 
Promoters
None
Held by 0 Schemes
Held by 0 FIIs
Dhairyasheel Vasantrao Yadav (13.26%)
Neville Maneckji (4.31%)
35.7%
Quarterly Results Snapshot (Standalone) - Dec'25 - YoY
Not Applicable: The company has declared_date for only one period
Not Applicable: The company has declared_date for only one period
Half Yearly Results Snapshot (Standalone) - Sep'25
Growth in half year ended Sep 2025 is 0.00% vs 0.00% in Sep 2024
Growth in half year ended Sep 2025 is 50.00% vs 33.33% in Sep 2024
Nine Monthly Results Snapshot (Standalone) - Dec'25
YoY Growth in nine months ended Dec 2025 is 0.00% vs -100.00% in Dec 2024
YoY Growth in nine months ended Dec 2025 is -222.22% vs 70.97% in Dec 2024
Annual Results Snapshot (Standalone) - Mar'25
YoY Growth in year ended Mar 2025 is 0.00% vs 0.00% in Mar 2024
YoY Growth in year ended Mar 2025 is 220.00% vs 0.00% in Mar 2024






